1/192
Looks like no tags are added yet.
Common properties of lipids
Insoluble in water, soluble in nonpolar solvents
Common structure of lipids
Hydrophobic carbon backbone with a head group
Micelle structure
Monolayer of lipids with hydrophobic tails facing the hydrophobic core and head groups facing the aqueous external environment
Vesicle structure
Bilayer of lipids with hydrophobic tails facing each other and head groups facing the hydrophilic core and aqueous external environment
Dyslipidemias
Accumulations of lipids in tissues and in the blood
Dietary purified lipids
Butter/oils, composed of very hydrophobic neutral TGs
Dietary cellular lipids
Neutral TGs/CEs from lipid droplets in muscles, amphipathic lipids from membranes
Composition of bile
Water, bile salts, PC, cholesterol
Bile released by
Gallbladder
Function of bile
Amphipathic, solubilise dietary lipids as micelles in the GI tract
Function of pancreatic lipase
Hydrolyses TGs to MAGs & FFAs in micelles in the GI tract
i-FABP function
Chaperones FFAs in enterocytes to transport them
FFA processing in enterocytes
FFAs are reassembled into TGs in the ER/Golgi, TGs are packed into chylomicrons at ER and secreted into the bloodstream
Factors that increase the MP of FAs
Longer carbon chain, less unsaturations, trans isomers, straight
Factors that decrease the MP of FAs
Shorter carbon chain, more unsaturations, cis isomers, branches
Nomenclature of FAs
number of carbons:number of unsaturations (DELTA)^position of unsaturations
TG composition
3 acyl chains + 1 glycerol
FA composition
Hydrocarbon chain + COOH head group
Phospholipids composition
2 acyl chains + glycerol + phosphate + polar head group
Cholesterol composition
Rigid steroid ring structure + hydrocarbon tail + polar head group
Metabolism of endogenous lipids
Synthesised by the liver, transported in VLDLs through blood, stored in adipose tissue, mobilised for energy generation
Metabolism of exogenous lipids
Ingested, solubilised by bile salts, broken down by pancreatic lipase, reassembled & packed into chylomicrons in enterocytes, transported through lymph & blood, stored in adipose tissue & liver, mobilised for energy generation
Regulation of pancreatic lipase
Substrate availability
Diffusion of FFAs into brush border cells
Acidification of pinocytic vesicles from pH 7 to pH 5, neutralising charged COO- cells for free diffusion across the membrane
Regulation of LPL
Substrate availability, activation by ApoC-II & inhibition by ApoC-III
Activity of LPL
Breaks down TGs in chylomicrons/VLDLs into FFAs + MAGs + glycerol for uptake to intestinal cells
LPL location
Bound to the extracellular side of the endothelial cell surface by polysaccharide chains
When does lipolysis occur
During prolonged exercise (hours)
Where does lipolysis occur
In lipid droplets stored in adipocytes and hepatocytes
Structure of a lipid droplet
Monolayer of TGs & CEs to form a hydrophobic environment
Clinical result of too many/large lipid droplets in the liver
Fatty liver and liver dysfunction
TG breakdown (lipolysis step 1)
TG to DAG + FA by ATGL
DAG breakdown (lipolysis step 2)
DAG to MAG + FA by HSL
MAG breakdown (lipolysis step 3)
MAG to FA + glycerol by MGL
Hormonal regulation of lipolysis
PKA stimulates phosphorylation of perilipin & HSL in response to epinephrine
Function of perilipin
Coat proteins on lipid droplets which undergo a conformational change when phosphorylated, organising more loosely to allow HSL inside the lipid droplet
FA transport following lipolysis
FFAs are released from adipocytes and associate with albumin in the bloodstream, transported to muscles and released for energy generation
Location of lipogenesis in enterocytes
Lipolysis occurs between the leaflets of the ER bilayer in enterocytes, from which TGs bud to form lipoproteins
Enterocyte lipogenesis step 1
CoA activation of FAs by acyl-CoA synthetase, releases PPi
Enterocyte lipogenesis pathway
2-MAG + CoA to DAG by MGAT, then DAG + CoA to TG by DGAT
Location of TG de novo synthesis
Liver and adipose tissue
de novo lipogenesis step 1
Generation of glycerol-3P from DHAP by G3PDH
Location of glycerol kinase
Liver
de novo lipogenesis step 2
Addition of 2 acyl-CoAs to glycerol-3P by GPAT & AGPAT
de novo lipogenesis step 3
Dephosphorylation of DAG-3P to DAG by lipin
de novo lipogenesis step 4
Addition of 1 acyl-CoA to DAG by DGAT to form TG
Regulation of lipogenesis
Insulin stimulates lipogenesis in adipose tissue by transcriptional control, substrate availability by glucose uptake through GLUT4
Sphingomyelin composition
Choline + phosphate + sphingosine + 1 acyl tail
Glycolipids composition
Sugar (galactose) + sphingosine + 1 acyl tail
PS head group
Serine
PE head group
Ethanolamine
PC head group
Choline
PI head group
Inositol
Effect of orlistat
Inhibition of pancreatic lipase, no digestion of TGs
Effect of olestra
Artificial fat additive that is non-hydrolysable by lipases, lipids not taken up in GI tract & accumulate, excreted as steatorrhea
Intake of PS from micelles
Interaction with NPC1L1
Efflux of PS from enterocytes
Through ABCG5/G8
Structure of lipoproteins
Circulating lipid carriers composed of a monolayer of polar surface lipids with apolipoproteins and a neutral lipid core
Apolipoprotein function
Amphipathic proteins that insert into lipoproteins and serve as ligands for lipoprotein docking and recognition
ApoC-II function
LPL co-factor/activator
ApoC-III function
LPL inhibitor
Chylomicron remnant receptors
LDLR and LRP in the liver
LDLR ligand
ApoE
LRP ligand
ApoB48
Chylomicron lifespan
Short-lived, cleared from circulation by uptake 1-2h after a meal
Endogenous lipid metabolism
Secreted by liver in VLDLs, move in capillaries, lipids broken down by LPL & FFAs taken up by tissues, IDL taken up by liver or metabolised by HL into LDL, LDL taken up at peripheral tissues
Why do peripheral tissues need cholesterol
To regulate PM fluidity, produce signalling molecules, synthesise membranes for cell division, transcriptional regulation
ApoB100 vs. ApoB48
Both formed from the same gene, exon skipping in enterocytes produces Apo48 which is 48% of the length of ApoB100
Chylomicron coat
Phospholipids, ApoE, ApoC-II, ApoC-III, ApoB48, cholesterol
Chylomicron core
Dietary TGs & CEs
VLDL coat
ApoB100, ApoC-II, ApoC-III, ApoE, cholesterol, phospholipids
VLDL core
Endogenous TGs & CEs
VLDL production
Continuous, by the liver
LDL coat
Phospholipids, cholesterol, ApoB100
LDL core
Endogenous TGs & CEs
LDL uptake mechanism
ApoB100 interacts with LDLRs on the surface of peripheral tissues
LDL uptake mechanism
LDLs are endocytosed as clathrin-coated vesicles, forming endosomes (pH 5) which merge with lysosomes to form secondary lysosomes, producing AAs, FAs, ACAT and recycling clathrin triskelions/LDLRs
Activity of CEs after LDL uptake
Act on LDLR synthesis at the ER and membrane formation at the Golgi apparatus
HDL coat
ApoA-I, Apo, ApoA-II, phospholipids, cholesterol
HDL core
TGs, CEs
Reverse cholesterol transport step 1
High cholesterol/ACAT induces the transcription of ABCA1 which flops cholesterol to the outer side of the PM & interacts with ApoA-I on pre-HDL
Reverse cholesterol transport step 2
ABCA1 dimerises and packages lipid-free ApoA-I with a small amount of lipids to discoidal HDL, which loses affinity for & dissociates from ABCA1
Reverse cholesterol transport step 3
Discoidal HDL matures to spherical HDL3 when cholesterol is esterified to CEs by LCAT (with PC co-factor), which move into the hydrophobic core
Reverse cholesterol transport step 4
CETP exchanges CEs & TGs between spherical HDL3 and VLDL, maturing HDL3 into HDL2
CETP activity
Tube-shaped channel with a hydrophobic centre, allowing TGs to diffuse from VLDL to HDL3 and CEs to diffuse from HDL3 to VLDL
HDL uptake (reverse cholesterol transport step 5)
HDL2 docks at SRB1 receptors and empties its cargo into the liver, lipid-poor ApoA-I is undocked
Fate of HDL components in the liver
TGs and phospholipids are hydrolysed, CEs are used to synthesise bile salts
Main bile salts
Glycocholate, taurocholate
Effect of LDLR deficiency
Too much LDL, high CVD risk
Effect of ABCA1 deficiency
Tangier disease, too little HDL, accumulation of CEs from LDL in cells, high CVD risk
Maintenance of phospholipid asymmetry
Balanced by flippase, floppase and scramblase
Membrane lipid microdomains
RAFTs (thick & stiff), non-RAFTs (thin & fluid)
RAFT microdomains composition
Gangliosides, sphingomyelin, cholesterol
non-RAFT microdomains composition
Glycerophospholipids (PC, PS, PE)
When is glycerophospholipid synthesis favoured?
During cell division, to maintain the balance of membrane RAFTs, to provide signalling molecules under stress
Location of biosynthesis of phospholipids/neutral lipids
ER
Phosphatidic acid synthesis
During de novo TG synthesis, addition of 2 acyl-CoAs to glycerol-3P
Glycerophospholipid synthesis step 1
Activation of phosphatidic acid by CDP-DAG synthase with CTP forms CDP-DAG + PPi, coupled to inorganic pyrophosphatase activity, overall irreversible
Glycerophospholipid synthesis step 2
Addition of inositol to CDP-DAG to form PI by PI synthase
Addition of glycerol-3P to CDP-DAG for form PG-3P by PG-3P synthase, then dephosphorylation to PG by PG-3P phosphatase
Use of PG synthesis
Converted to cardiolipin & glycerol by cardiolipin synthase, for lipids going into the mitochondria